IMMUNOKEY LTD
Significant control: Robert Hawkins (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
What does Immunokey Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
IMMUNOKEY LTD is an active private limited company (company number 15495377) incorporated on 16 February 2024, registered in Wilmslow. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 28 February 2025, showing net assets of £124k and cash of £95k, with 5 employees on average.
By net assets it sits in the upper half of 138 comparable companies in Manchester (median £436, upper quartile £124k).
Ownership and control
- Robert Hawkins
- owns 25–50% of shares
- holds 25–50% of voting rights
- Dr Robert Edward Hawkins
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- Gray Kueberuwa
- owns 25–50% of shares
- Dr Nicola Price
- owns 25–50% of shares
- holds 25–50% of voting rights
- Dr Ryan Guest
- owns 25–50% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 16 February 20242 yrs ago
- Next accounts due
- 28 November 2026in 36 days
- Confirmation statement due
- 2 March 2027in 130 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- SIC 74909
- Other professional, scientific and technical activities n.e.c.
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 28 February 2025 | £124k | £95k | £48k | £56k | — | — | 5 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £123,657 at 28 February 2025
- Current assets at least 1.5× creditors within one yearCurrent ratio 2.54
- Cash at bank of £50,000 or moreCash £95,486
- Incorporated two to five years agoIncorporated 16 February 2024
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 130 days
- Next accounts duein 36 days
- Accounts period endNet assets £124k · small accounts
- Incorporated
Similar companies in Manchester
- MOLECULAR GLUE LABS LTDAltrincham · inc. Feb 2024
- INTEGRATED BIOLOGIX LTDWarrington · inc. Jan 2024
- BIOMARKER TECHNOLOGIES (BMKGENE) UK LTDMacclesfield · inc. Jan 2024
- REDDINGTON VENTURES LTD.Manchester · inc. Mar 2024
- ETERNA BIOLOGICS LTDAltrincham · inc. Mar 2024
- BIOSECURE ID LIMITEDMacclesfield · inc. Mar 2024
All companies incorporated on 16 February 2024 · in Feb 2024.
Reminders for IMMUNOKEY LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.